WEEKLY ADMINISTRATION OF PACLITAXEL IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS

被引：0
|
作者：
Lombardo, Laura [1 ]
Mucciarini, Claudia [1 ]
Castagnetti, Giovanni [1 ]
Nicolini, Massimiliano [1 ]
Maur, Michela [1 ]
Frassoldati, Antonio [1 ]
Conte, Pier Franco [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Div Med Oncol, Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [1] Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer
    Chiappino, Isabella
    Destefanis, Paolo
    Addeo, Alfredo
    Galetto, Alessandra
    Cucchiarale, Giuseppina
    Munoz, Fernando
    Zitella, Andrea
    Ferrando, Ugo
    Fontana, Dario
    Ricardi, Umberto
    Tizzani, Alessandro
    Bertetto, Oscar
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 234 - 238
  • [2] Weekly paclitaxel plus estramustine phosphate in hormone-refractory prostate cancer
    Roth, BJ
    Hudes, GR
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 137 - 137
  • [3] Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients
    Kojima, T
    Shimazui, T
    Onozawa, M
    Tsukamoto, S
    Hinotsu, S
    Miyanaga, N
    Hattori, K
    Kawai, K
    Akaza, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (03) : 137 - 141
  • [4] Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer
    Copur, MS
    Ledakis, P
    Lynch, J
    Hauke, R
    Tarantolo, S
    Bolton, M
    Norvell, M
    Muhvic, J
    Hake, L
    Wendt, J
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 16 - 21
  • [5] Paclitaxel in the treatment of hormone-refractory prostate cancer
    Smith, DC
    Pienta, KJ
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 109 - 111
  • [6] Clinical evaluation of weekly 1-hour infusion of paclitaxel in patients with hormone-refractory prostate cancer
    Hussain, M
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 138 - 138
  • [7] A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer
    Berry, William
    Friedland, David
    Fleagle, John
    Jackson, Dori
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 131 - 137
  • [8] Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer
    Yasufuku, Tomihiko
    Shigemura, Katsumi
    Matsumoto, Osamu
    Arakawa, Soichi
    Fujisawa, Masato
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (03) : 200 - 205
  • [9] Weekly docetaxel for advanced hormone-refractory prostate cancer
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V.
    Leonardi, V.
    Laudani, A.
    Arcuri, C.
    Giresi, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2006, 17 : VII154 - VII154
  • [10] Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer
    Haas, N
    Roth, B
    Garay, C
    Yeslow, G
    Entmacher, M
    Weinstein, A
    Rogatko, A
    Babb, J
    Minnitti, C
    Flinker, D
    Gillon, T
    Hudes, G
    UROLOGY, 2001, 58 (01) : 59 - 64
12345